글로벌 생체동일 호르몬 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

생체동일 호르몬 시장 분석

오늘날의 빠른 속도와 스트레스 속에서 호르몬 불균형을 경험하는 것은 특히 여성에게 정상적인 일입니다. 다양한 종류의 호르몬 변화로 인해 여성의 몸은 질병과 이상을 겪게 되고 이는 노화로 인해 악화됩니다. 호르몬 불균형은 체중 증가, 기억력 저하, 피로, 근육 감소와 같은 문제를 초래합니다.

생체동일 호르몬 시장 규모

글로벌 생체동일 호르몬 시장 규모는 2023년에 38억 1천만 달러로 평가되었으며, 2031년까지 63억 5천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 6.61%입니다.

보고 범위 및 시장 세분화       

생체동일 호르몬 시장 정의

Bioidentical hormones are manmade hormones which are used to treat low or out of balance hormonal levels. Bioidentical hormones are similar to the hormones that are naturally produced in the body of both men and women. Bioidentical hormones are used to treat the hormonal imbalance and its effects on and in the body. Normally, hormonal imbalance in men is experienced after 40 years of age.

Bioidentical Hormones Market Dynamics

Drivers

• The rise in the prevalence of hormonal deficiency

Surging prevalence of hormonal deficiency especially in women all around the globe owing to various internal and external factors is one of the major factors responsible for fostering growth of the market. Rising patient pool especially in the developing economies is carving the way for the growth of the market.

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies have led to the advancements in the medical technology and have improved the quality of healthcare facilities.  Increasing number of screening tests for research proficiencies has further widened the scope of growth.

• Government investments on healthcare infrastructure

The increase in the funding by the federal government is set to drive the growth of the market. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative personal health devices market growth opportunities. Also, growing acceptance of bioidentical hormones replacement therapy by the governmental healthcare facilities is also bolstering the market growth rate.

Additionally, surge in the personal disposable income level, introduction of technologically driven product in hospitals and increasing investment for the development of advanced and rise in focus on women health care and treatment of hormonal imbalances, positively affect the market growth rate.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, increasing need for improvised healthcare services owing to imbalance between health workforce and patients and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising lifestyle changes, increased stress and work pressure, irregular eating habits, and lack of exercise, growing number of hospitals and laboratories, rising geriatric population base, rising number of cross-industry partnerships and collaborations and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high cost associated with the research and development proficiencies, safety issues related to the use of compound bioidentical hormones and difficulties related with the medical procedures are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, various side effects such as weight loss and blurred vision, high risk of heart attack and breast cancer and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2024-2031.

This bioidentical hormones market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bioidentical hormones market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Bioidentical Hormones Market

Covid-19 has had a negative impact on the market. Reduced focus on non-essential medical procedures and postponement of healthcare procedures has put a dent on the market growth rate. Moreover, halt on the number of research and development proficiencies further restricted the scope of growth in the pandemic phase.  

Bioidentical Hormones Market Scope

The bioidentical hormones market is segmented on the basis of type, product type, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Estrogens
• Progesterone
• Testosterone
• Combined Hormones
• Others

On the basis of type, the bioidentical hormones market is segmented into estrogens, progesterone, testosterone, combined hormones and others.

Product type

• Tablets and Capsules
• Creams and Gels
• Injectable
• Patches and Implants
• Others

Based on product type, the bioidentical hormones market is segmented into tablets and capsules, creams and gels, injectable, patches and implants and others. 

Distribution channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

On the basis of distribution channel, the bioidentical hormones market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

End user

• Hospital
• Gynaecology Clinics
• Academic and Research
• Others

The end user segment of the bioidentical hormones market is segmented into hospital, gynaecology clinics, academic and research and others.

Bioidentical Hormones Market Regional Analysis

The bioidentical hormones market is analysed and market size insights and trends are provided by country, type, product type, distribution channel and end user as referenced above.

The countries covered in the bioidentical hormones market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the bioidentical hormones market because of the strong base of healthcare facilities, availability of reimbursements, rising geriatric population, high healthcare spending combined with the onset of COVID-19 pandemic and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, ever-rising geriatric population base and the growing demand for quality healthcare in the region.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

생체동일 호르몬 시장은 또한 모든 국가에 대한 자세한 시장 분석, 자본 장비에 대한 의료 지출 증가, 생체동일 호르몬 시장을 위한 다양한 종류의 제품 설치 기반, 생명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 생체동일 호르몬 시장에 미치는 영향을 제공합니다. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

생체동일 호르몬 시장 점유율

생체동일 호르몬 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 생체동일 호르몬 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 생체 동일 호르몬 시장 리더는 다음과 같습니다.

• 소토펠레(미국)
• 노바티스 AG(스위스)
• Orion Pharma AB(스웨덴)
• 풀 라이프 웰니스 센터(미국)
• BioTE Medical, LLC(미국)
• 머크 KGaA(독일)
• 파이저 주식회사(미국)
• TherapeuticsMD, Inc. (미국)
• Papillon Medical(캐나다)
• 유나이티드 파마시(미국)
• Noven Pharmaceuticals, Inc. (미국)
• GEA 그룹 Aktiengesellschaft(독일)
• Novo Nordisk A/S(덴마크)
• GeneScience Pharmaceuticals Co., Ltd.(중국)
• Actiza Pharmaceutical Private Limited(인도)
• 디파이 메디컬(미국)
• Neuva Aesthetics (미국)
• ZRT 연구실(미국)
• Bayer AG(독일)
• 알러간(아일랜드)

생체동일 호르몬 시장의 최신 동향

• 2020년 8월, 미국 FDA는 성장호르몬 결핍증이 있는 성인 환자를 위한 인간 성장호르몬(HGH) 치료제인 Sogroya(소마파시탄)를 승인했습니다. 이 제품은 피부 아래 주사로 주 1회 복용하도록 적응증이 있습니다.
• 2020년 12월, 미국 FDA는 VistaPharm의 티퀴디티(레보티록신) 경구 용액을 1차(갑상선), 2차(뇌하수체), 3차(시상하부) 선천성 난소 낭종의 대체 요법으로 승인했습니다.
• 2020년 12월, 미국 FDA는 경구 투여 치료제인 Myovant Sciences의 Orgovyx(relugolix)를 승인했습니다.
• 2020년 8월, Bayer AG는 KanDy Therapeutics Inc.의 인수를 발표했습니다. 이를 통해 Bayer는 KanDy의 폐경 치료제를 포트폴리오에 추가하여 여성 약물 파이프라인을 확대할 수 있게 되었습니다.

SKU-13211